ARIAD PHARMACEUTICALS INC Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term (Deprecated 2012-01-31)
ARIAD PHARMACEUTICALS INC reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term (Deprecated 2012-01-31) of 4.07 Year for the 12-month period ending 2011-12-31, per its 10-K/A filed 2012-03-30.
Discontinued › Notes › Compensation Related Costs
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm · last filed 2012-03-30
- ARIAD PHARMACEUTICALS INC share-based compensation arrangement by share-based payment award, options, exercisable, weighted average remaining contractual term (deprecated 2012-01-31) for fiscal 2011 was 4.07 Year.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term (Deprecated 2012-01-31) 12 month |
|---|---|
| 2011-12-31 | 4.07 Year 10-K/A · filed 2012-03-30 |